Hua Xia Healthcare Holdings Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hua Xia Healthcare Holdings Limited with three other
companies in this sector in Hong Kong:
Hin Sang Group (International) Holding Co Ltd
sales of 201.82 million Hong Kong Dollars [US$25.81 million]
of which 89%
was Product Development Segment),
Extrawell Pharmaceutical Holdings Limited
(107.90 million Hong Kong Dollars [US$13.80 million]
of which 59%
was Trading), and
Hong Kong Life Sciences and Technologies Group Ltd
(153.57 million Hong Kong Dollars [US$19.64 million]
of which 79%
was Trading Business).
Sales fell dramatically in 2017:
Hua Xia Healthcare Holdings Limited reported sales of HK$269.52 million (US$34.47 million)
March of 2017.
decrease of 82.9%
versus 2016, when the company's sales were HK$1.57 billion.
Contributing to the drop in overall sales was the 29.0% decline
in Pharmaceutical Wholesale, from HK$1.32 billion to HK$938.03 million.
However, these declines were partially offset by the increase in sales of
Provision of General Hospital Services (up 6.6% to HK$269.52 million)